Evidence map›Paper›PMID 33135114›Full record

ReviewJournal of the Egyptian National Cancer Institute2020

Systemic recurrence of endometrial cancer more than 10 years after hysterectomy: a report of two cases and a brief review of the literature.

Leonardo Muratori, Paola Sperone, Gabriella Gorzegno, Anna La Salvia, Giorgio Vittorio Scagliotti

Open access · diamondAbstract readCase ReportsReview
In one paragraph

Review in Journal of the Egyptian National Cancer Institute, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Leonardo MuratoriMedical Oncology, Department of Oncology, Azienda Ospedaliera Universitaria San Luigi Gonzaga, University of Turin, Regione Gonzole 10, 10043 Orbassano, Turin, Italy. muratorileonardo@gmail.com.ORCID http://orcid.org/0000-0003-4443-0232
Paola SperoneMedical Oncology, Department of Oncology, Azienda Ospedaliera Universitaria San Luigi Gonzaga, University of Turin, Regione Gonzole 10, 10043 Orbassano, Turin, Italy.
Gabriella GorzegnoMedical Oncology, Department of Oncology, Azienda Ospedaliera Universitaria San Luigi Gonzaga, University of Turin, Regione Gonzole 10, 10043 Orbassano, Turin, Italy.
Anna La SalviaMedical Oncology, Department of Oncology, Hospital Universitario 12 de Octubre, Avenida Cordoba, s/n, 28041, Madrid, Spain.
Giorgio Vittorio ScagliottiMedical Oncology, Department of Oncology, Azienda Ospedaliera Universitaria San Luigi Gonzaga, University of Turin, Regione Gonzole 10, 10043 Orbassano, Turin, Italy.
Ospedale San Luigi Gonzaga · ITHospital Universitario 12 De Octubre · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEndometrial carcinoma is one of the most common female cancers in developed countries. Disease stage is associated with the risk of disease relapse after radical treatment. Typically, the risk of disease relapse peaks at 3 years from local radical treatment and then diminishes over time, so that late relapses (i.e., from year 5 afterward) are extremely infrequent. Here, we report two cases of women with endometrial cancer who developed a disease relapse more than 15 years after radical treatment. A review of the literature revealed other seven reports of women with relapse from endometrial cancer occurring more than 10 years after radical treatment. CASE PRESENTATION: Case report 1 is a 56-year-old woman with an endometrioid cancer who underwent a hysterectomy with bilateral salpingo-oophorectomy in 1998. She relapsed in the lung in 2014, 16 years from radical surgery. Case report 2, a 75-year-old woman, with an endometrioid cancer, was treated by hysterectomy with bilateral salpingo-oophorectomy and adjuvant radiotherapy. The disease relapse in the lung was detected in 2019, 22 years from radical treatment.

conclusionAlthough guidelines do not support oncological follow-up beyond 5 years from surgery, oncologists should consider late recurrence of endometrial carcinoma in the differential diagnosis of women presenting with metastases of uncertain origin and prior history of this disease.

Indexed as

Endometrial NeoplasmsHysterectomyNeoplasm Recurrence, LocalAgedFemaleHumansMiddle AgedNeoplasm StagingRadiotherapy, AdjuvantCancerCarcinomaEndometrialRecurrenceRelapse

Identifiers

PMID33135114
PMCPMC13317113
OpenAlexW3096124986

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.